I didn’t start in the boardroom. I started in the dirt — literally — hauling rocks, planting trees, and laying pavers before I ever learned what EBITDA meant. 1 of 5 kids, competition was oxygen. Work ethic wasn’t optional; it was survival.
​
At sixteen, I split time between high school and business lectures at the University of Michigan. By my early twenties, I was managing a $10M medical device territory — too young to rent a car, but old enough to close a deal. I learned fast: from surgeons in the OR, CFOs across the table, and mentors who didn’t sugarcoat feedback.
​
That’s where the obsession started — understanding how innovation actually becomes adoption. Not theory, not slides, but the real work of getting a technology funded, approved, reimbursed, and trusted.
​
Two decades later, I’ve operated inside more than twenty companies  — from first-in-class startups to global strategics. I’ve been brought in when growth stalled, markets shifted, or investors needed traction. I’ve rebuilt teams, restored EBITDA, secured regulatory and reimbursement access, and repositioned assets for IPOs, M&A, and growth equity.
​
I’m not the “steady-state” hire. I’m the one who shows up when it’s messy — when there’s too much strategy and not enough execution. I help businesses find clarity, rebuild confidence, and move from stuck to scaling.

Today, I lead MJM Advisory Group, where I embed as a CxO or strategic advisor for companies that need results, not reports.
​
Outside of that, I stay close to the next generation of innovators as a mentor with MedTech Innovator, helping early-stage teams turn clinical promise into commercial reality.
​
I believe execution is the strategy. Build great teams, move fast, stay humble, and laugh when you can — because the work’s too hard not to enjoy it.